Artivion | CRY - Gross Profit On Sales

Stock Price
36.39
Daily Change
0.22 0.61%
Monthly
-0.30%
Yearly
50.87%
Q1 Forecast
35.29

Artivion reported $61.01M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 38.86M 1.05M Feb/2025
Artivion USD 61.01M 2.32M Sep/2024
AtriCure USD 105.34M 4M Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Boston Scientific USD 3.68B 136M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Integra LifeSciences USD 217.1M 10.11M Dec/2025
J&J USD 16.6B 118M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 545.88M 410.83M Dec/2024
Pfizer USD 3.54B 7.61B Sep/2025
ResMed USD 878.72M 57.9M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025